Compile Data Set for Download or QSAR
Report error Found 218 Enz. Inhib. hit(s) with all data for entry = 12462
TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704237BDBM704237((Table 4) | US12139488, Example 420)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704267BDBM704267((Table 4) | US12139488, Example 662)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704295BDBM704295(US12139488, Example 314)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704278BDBM704278(US12139488, Example 13)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704211BDBM704211(US12139488, Example 115)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704241BDBM704241((Table 4) | US12139488, Example 467)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704300BDBM704300(US12139488, Example 319)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704210BDBM704210(US12139488, Example 100)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704240BDBM704240((Table 4) | US12139488, Example 465)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704270BDBM704270((Table 4) | US12139488, Example 681)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704209BDBM704209(US12139488, Example 96)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704282BDBM704282(US12139488, Example 21)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704298BDBM704298(US12139488, Example 317)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704281BDBM704281(US12139488, Example 20)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704297BDBM704297(US12139488, Example 316)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704272BDBM704272(US12139488, Example 6)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704244BDBM704244((Table 4) | US12139488, Example 484)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704206BDBM704206(US12139488, Example 3)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704212BDBM704212(US12139488, Example 116)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704242BDBM704242((Table 4) | US12139488, Example 472)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704233BDBM704233(US12139488, Example 382)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704264BDBM704264(4) | US12139488, Example 619)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704291BDBM704291(US12139488, Example 30)
Affinity DataIC50: 1nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704296BDBM704296(US12139488, Example 315)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704236BDBM704236(US12139488, Example 415)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704235BDBM704235(US12139488, Example 392)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704294BDBM704294(US12139488, Example 313)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704293BDBM704293(US12139488, Example 312)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704299BDBM704299(US12139488, Example 318)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704238BDBM704238((Table 4) | US12139488, Example 424)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704288BDBM704288(US12139488, Example 27)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704229BDBM704229(4) | US12139488, Example 357)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704287BDBM704287(US12139488, Example 26)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704228BDBM704228(US12139488, Example 356)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704286BDBM704286(US12139488, Example 25)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704285BDBM704285(US12139488, Example 24)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704292BDBM704292(US12139488, Example 31)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704232BDBM704232(4) | US12139488, Example 376)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704290BDBM704290(US12139488, Example 29)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704230BDBM704230(4) | US12139488, Example 362)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704253BDBM704253((Table 4) | US12139488, Example 513)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704252BDBM704252(4) | US12139488, Example 512)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704251BDBM704251(4) | US12139488, Example 511)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704257BDBM704257((Table 4) | US12139488, Example 522)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704256BDBM704256(US12139488, Example 521)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704255BDBM704255(US12139488, Example 520)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704254BDBM704254((Table 4) | US12139488, Example 514)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704245BDBM704245(US12139488, Example 486)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704304BDBM704304(US12139488, Example 323)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Université

US Patent
LigandChemical structure of BindingDB Monomer ID 704303BDBM704303(US12139488, Example 322)
Affinity DataIC50: 5.5nMAssay Description:In vitro enzymatic reactions were used for evaluating compounds intrinsic activity against BRAF, CRAF and ARAF. For BRAF and CRAF, 0.375 nM of purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/18/2025
Entry Details
US Patent

Displayed 1 to 50 (of 218 total ) | Next | Last >>
Jump to: